Issued Patents All Time
Showing 25 most recent of 40 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11919903 | Polymorphs | Dirk Kemmer, Peter KOHLBAUER, Thomas Nicola, Martin Renz | 2024-03-05 |
| 11447474 | Solid forms of a GlyT1 inhibitor | Joe Ju GAO, Bing-Shiou Yang | 2022-09-20 |
| 11084819 | Polymorphs | Dirk Kemmer, Peter KOHLBAUER, Thomas Nicola, Martin Renz | 2021-08-10 |
| 10301313 | Polymorphs | Dirk Kemmer, Peter KOHLBAUER, Thomas Nicola, Martin Renz | 2019-05-28 |
| 9815837 | Polymorphs | Dirk Kemmer, Peter KOHLBAUER, Thomas Nicola, Martin Renz | 2017-11-14 |
| 9493462 | Polymorphs | Dirk Kemmer, Peter KOHLBAUER, Thomas Nicola, Martin Renz | 2016-11-15 |
| 9309228 | Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof | Markus Ostermeier | 2016-04-12 |
| 9266888 | Polymorphs | Dirk Kemmer, Peter KOHLBAUER, Thomas Nicola, Martin Renz | 2016-02-23 |
| 9212183 | Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine | Waldemar Pfrengle | 2015-12-15 |
| 8906931 | 9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof | Waldemar Pfrengle, Guenther Huchler, Markus Ostermeier | 2014-12-09 |
| 8865729 | Salt forms of a xanthine compound | Waldemar Pfrengle | 2014-10-21 |
| 8853225 | 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof | Waldermar Pfrengle, Guenther Huchler, Markus Ostermeier | 2014-10-07 |
| 8686148 | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | Rolf Banholzer, Waldemar Pfrengle | 2014-04-01 |
| 8664222 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Guenter Linz, Matthias Grauert, Rolf Schmid | 2014-03-04 |
| 8637530 | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals | Waldemar Pfrengle | 2014-01-28 |
| 8426586 | Process for preparing amino crotonyl compounds | Rainer Soyka, Werner Rall, Juergen Schnaubelt, Christian Kulinna | 2013-04-23 |
| 8329695 | Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide | Guenter Linz, Rolf Schmid, Stefan Goepper | 2012-12-11 |
| 8202867 | Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide | Guenter Linz, Gerd Kraemer, Matthias Hoffmann | 2012-06-19 |
| 8188086 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Guenter Linz, Matthias Grauert, Rolf Schmid | 2012-05-29 |
| 8106060 | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals | Waldemar Pfrengle | 2012-01-31 |
| 8034809 | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments | Philipp Lustenberger, Ingo Konetzki | 2011-10-11 |
| 8034816 | Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | Guenter Linz, Gerd Kraemer, Rolf Herter, Matthias Hoffmann, Werner Rall +1 more | 2011-10-11 |
| 7968717 | Crystalline anhydrate with anticholinergic efficacy | Waldemar Pfrengle | 2011-06-28 |
| 7939658 | Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof | Uwe Ries | 2011-05-10 |
| 7932273 | 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament | Rolf Schmid, Rainer Sobotta | 2011-04-26 |